Proc.Nat!.Acad.Sci.USAVol.86,pp.6812-6815, September 1989Neurobiology
cGMPinduces phaseshiftsofamammalian circadian pacemaker at
night,inantiphase tocAMPeffects
(suprachiasmatic nuclei/circadian rhythms/brain slice/circadian dock/rat)
REBECCA A.PROSSER*, ANGELA J.MCARTHURt, ANDMARTHA U.GILLETTE*t1
University ofIllinoisatUrbana-Champaign, *NeuralandBehavioral BiologyProgram, andtDepartment ofPhysiology andBiophysics, 524BurrillHall,407
SouthGoodwin, Urbana, IL61801
Communicated byC.LaddProsser, June19,1989
ABSTRACT Thesuprachiasmatic nuclei(SCN)ofmam-
malscontainacircadian clockthatsynchronizes behavioral
andphysiological rhythms tothedailycycleoflightand
darkness. Wehavebeenprobingthebiochemical substrates of
thisendogenous pacemaker byexamining theabilityoftreat-
mentsaffecting cyclicnucleotide-dependent pathways toinduce
changesinthephaseofoscillation inelectrical activityofrat
SCNisolatedinbrainslices.Ourpreviousworkhasshownthat
daytimetreatments thatstimulate cAMP-dependent pathways
inducephaseshiftsoftheSCNpacemaker invitrobuttreat-
mentsduringthesubjective nightarewithouteffect.Inthis
studywereportthatthephaseofSCNoscillation isresetby
treatments thatstimulate cGMP-dependent pathways, butonly
duringthesubjective night.Thus,thenocturnal periodofSCN
sensitivity tocGMPisinantiphase tothediurnalperiodof
sensitivity tocAMP.TheseresultssuggestthatcAMPand
cGMPaffecttheSCNpacemaker throughseparatebiochemical
pathways intrinsictotheSCN.Thesestudiesprovideevidence
thatchanging biochemical substrates withintheSCNcircadian
clockmayunderlie someaspectsofdiferential temporal sen-
sitivityofmammals toresetting stimuli.
Mammals, likeothereukaryotic organisms, possessanen-
dogenous pacemaker thatkeepsnear24-hrtime(1).This
circadian clock,whichcanbeentrained bytheenvironmental
lightingcycle,organizes ananimal's behavior andphysiology
intodailyrhythms. Theprimarycircadian clockinmammals
islocatedinthesuprachiasmatic nuclei(SCN)(2,3).The
endogenous natureofthisoscillator isapparent fromexper-
imentsdemonstrating thattheSCNgenerate astablecirca-
dianrhythmofneuronal activityforatleastthreecycleswhen
isolatedinahypothalamic brainslice(4,5).Furthermore, the
pacemaker appearsunperturbed bytheprocessofbrain-slice
preparation duringtheanimal's day(6)sincethisinvitro
rhythmmatches therhythmofelectrical activityproduced by
theSCNinvivo(7).
Circadian rhythms inintactanimals areresetbystep
changesinconstant lightingconditions atdifferent phasesof
theirentrained lightingcycle.Organisms undergocircadian
changesinsensitivity toresetting stimulisothatinconstant
darkness theirrhythms areresetby15-minpulsesoflight
duringthenight,butnottheday(8,9).Conversely, in
constantlighttheirrhythms areadvanced by2-to3-hrpulsesofdarkness primarily whentheyoccurduringtheday,
although longer(6hr)pulsesofdarkness caninducedelays
duringthenight(10,11).Specificneurotransmitters injected
intotheSCNregioncanalsoinducephaseresetting of
behavioral rhythms (12-17). Likephoticstimuli,theireffi-
cacyisusuallylimitedtoaspecificportionofthecircadian
cycle,although theresultsoftheinvivopharmacological
studiesaresometimes contradictory (13,15-17).Thecellularbasisofcircadian changeinsensitivity toresetting stimuliis
unknown andisthesubjectofourinvestigations.
Wehavebeenstudying theresetting characteristics ofthe
SCNcircadian pacemaker invitro.Thisapproach should
revealwhichproperties predicted frominvivostudiesare
endogenous tothisbiological clockandshouldallowidenti-
ficationoftheirbiochemical substrates. Inearlierexperi-
mentsweshowed(4,5)thatinvitrotreatments thatincrease
endogenous cAMPlevelsresetthephaseoftheSCNclock
whenappliedduringsubjective day(thetimeoflights-on in
thedonorcolony)butnotduringsubjective night.These
resultssuggested thatchanging sensitivity tocAMP,within
eitheranentrainment pathway ortheclockmechanism, may
underlie thesensitivity oftheorganism tosomedaytime
phase-shifting stimuli.Tofurtherprobebiochemical mecha-
nismsassociated withtheSCNclock,wehaveinvestigated
theabilityoftreatments thatstimulate cGMP-dependent
pathways toresettheSCNclockinvitro.cAMPandcGMP
areinvolved inawidevarietyofcellfunctions (18,19),
sometimes inanantagonistic relationship (20),andsoitwas
ofinteresttodetermine whether theSCNclockshowsa
differentsensitivity tocGMPascompared withitssensitivity
tocAMP.
MATERIALS ANDMETHODS
Thepreparation, maintenance, andrecording procedures
usedintheseexperiments havebeenreported indetail(5).
Briefly,500-,umcoronalbrainsliceswereprepared during
lights-on fromadultLong-Evans ratsborninourinbred
colonyandhousedunder12hroflight/12hrofdarkcondi-
tions.Slicesweremaintained inabrain-slice chamber (21)
continuously perifused withEarle'sbalanced saltsolution
(GIBCO) supplemented with24.6mMglucoseand26.2mM
sodiumbicarbonate (pH7.4)at370Candsaturated withan
atmosphere of95%02/5%CO2.Inthe3-dayexperiment,
0.5%gentamicin wasaddedtotheperifusion medium that
wassterilized byfiltration. Atvarioustimesafterslice
preparation, perifukion wasstopped andthebathmedium
wasreplaced for1hrwithfreshlymademediumcontaining
either0.5mM8-bromoguanosine 3',5'-cyclic monophos-
phate(Br-cGMP) or0.5mMN2,02'-dibutyrylguanosine3',5'-cyclic monophosphate (Bt2-cGMP) atpH7.4thathad
beenoxygenated andwarmedfor5min.Thesemembrane-
solubleanalogsofcGMPactivatecGMP-dependent protein
kinasesandresistdegradation byphosphodiesterase (22,23).
After1hrthismedium wasreplaced completely withnormal
medium, andperifusion wasresumed. Previous experiments
Abbreviations: BzA-cAMP, 8-benzylaminoadenosine 3',5'-cyclicmonophosphate; Br-cGMP, 8-bromoguanosine 3',5'-cyclic mono-
phosphate; CT,circadian time;Bt2-cGMP, N202'-dibutyrylgua-nosine3',5'-cyclic monophosphate; SCN,suprachiasmatic nuclei.tTowhomreprintrequests shouldbeaddressed.
6812Thepublication costsofthisarticleweredefrayed inpartbypagecharge
payment. Thisarticlemusttherefore beherebymarked"advertisement"
inaccordance with18U.S.C.§1734solelytoindicatethisfact.
Proc.Natl.Acad.Sci.USA86(1989) 6813
haveshownthattheprocedure ofchanging theperifusion
mediumbyitselfdoesnotphase-shift theSCNclock(4).
Ineachexperiment theeffectofthistreatment uponthe
circadian pacemaker wasassessed bymonitoring thesubse-
quentcycle(s)ofneuronal activityinoneSCN.Thesponta-
neousactivities ofsingleSCNcellsencountered atrandom
throughout thenucleus weremonitored extracellularly by
usingglassmicroelectrodes filledwith5MNaCl.Only
clearlyisolatedsingleunitswithasignal/noise ratioof-2
werestudied.Afterassessing thestabilityofitsfiringrate,
eachcellwasmonitored fortwo120-secperiodsusing10-sec
binsandthenthemeanfiringratewasdetermined. On
average, fourcellsweremonitored perhouroverthecourse
of7-18hrduringeachexperiment. Thefiringratesof
individual cellswereaveraged over2-hrintervals using1-hr
lagstoobtainameasure oftheSCNneuronal population's
circadian rhythmoffiringrate,andfromthiswedetermined
thetimeofpeakfiringrateinthecircadian cycle(s)after
treatment.
Ourprevious workshowedthatthetimeofpeakneuronal
activityrecorded fromSCNinuntreated slicesvarieslittle
acrossanimalsfromourinbredline(6).Furthermore, the
rhythmremainsstableforatleast3daysinvitro:themean
timeofpeakelectrical activityinunperturbed slicesoccursat
circadian time(CT)7.1±0.1hr(n=3),6.9±0.2hr(n=8),
and6.6±0.4hr(n=3)ondays1-3invitro,respectively
(whereCTdividesthecircadian cycleinto24hrandCT0=
lights-on inthedonorcolony)(5).Thusthetimeofpeak
activityisareliablemeasure ofthephaseoftheunderlying
circadian pacemaker, andwecould,therefore, determine
phaseshiftsbycomparing thetimeofpeakactivityintreated
sliceswiththatofuntreated slices(5).
RESULTS
Treatment withBr-cGMP duringthemiddleofsubjective day
hadlittleeffectuponthesubsequent timeofpeakactivity.
Forexample, asshowninFig.IA,afterBr-cGMP treatment
between CT7-8onday1invitrotheelectrical activity
rhythmpeaked atCT6.25ofday2,indicating aphase
advanceof0.65hr.Theresultsof1-hrBr-cGMP treatments
duringthesubjective daytime aresummarized inthephase-
response curveinFig.2,wheretheresponse ofthepace-
maker(thechangeinthetimeofpeakactivityineach
experiment) isplottedaccording tothecircadian phaseofthe
treatment. Ascanbeseen,Br-cGMP treatments between CT
0and11inducedphaseshiftsrangingfrom-0.75to1.25hr,
withameanphaseadvance of0.24±0.24hr(n=8).
Incontrast todaytimetreatments, application ofBr-cGMP
duringsubjective nightinducedlargeshiftsinthephaseofthe
electrical activityrhythm, withthemagnitude ofphase
changedependent uponthetimeoftreatment. Forexample,asshowninFig.1B,treatment atCT18-19induced aphase
advanceof6.5hr,suchthatthepeakinactivityoccurred at
CT0.5.Overall, themeanphaseadvance inducedby1-hr
Br-cGMP treatments betweenCT12and22was4.38±0.71
hr(n=10).Thephaseshiftsinducedbythesenocturnal
Br-cGMP treatments aresummarized inFig.2.Thelargestphaseadvances, 6-7hr,occurred after1-hrBr-cGMP treat-
mentsbetween CT16and18,withsmalleradvances induced
bytreatments earlierandlaterduringthesubjective night.
Theresponses tonighttime Br-cGMP treatments were
stableacrosstwocycles,asshowninFig.3.Theadvanced
time-of-peak (atCT0.5)observed duringthefirstcycleafter
treatment wasseenagainnearly24hrlater(atCT1.0)duringthesecondcycleaftertreatment. Thisindicates thatBr-
cGMPtreatment for1hratCT18completely resetsthe
underlying circadian pacemaker duringthefirst6hrafter
treatment.6+
0-%
N
w
W4)
0*;44
2
10
8
6
4
21
h481216202448A
+i
B
4-4
12
Circadian time(hr)
FIG.1.Differential effectsofBr-cGMP ontheSCN'srhythmof
electrical activity. Plottedarerunning2-hrvalues(mean±SEM),laggedby1hr,ofallsingleunitsrecorded inindividual experiments
according tothecircadian timeatwhichtheywererecorded. (A)
Br-cGMP (0.5mM)treatment atCT7-8hadlittleeffectonthephaseoftheelectrical activityrhythminthecycleaftertreatment, sothat
thesubsequent timeofpeakactivityoccurred atCT6.25.(B)
Br-cGMP treatment atCT18-19phase-advanced thesubsequent
timeofpeakactivityby6.5hr,toCT0.5.Horizontal stippledbar,
subjective nightfortheSCN,thetimeoflights-off inthedonor
colony;verticalhatchedbar,timeoftreatment; dottedline,mean
timeofpeakactivity inuntreated slices;arrow,timeoftissue
preparation.
IfthephaseshiftsinducedbyBr-cGMP treatment atnight
weretheresultofspecifically stimulating cGMP-dependent
pathways, thentreatment withotheractiveanalogsofcGMP
shouldinducesimilarshifts.Totestthis,wetreatedslices
withBt2-cGMP, theonlyothercGMPanalogwefound
commercially available, attwocircadian times.Application
of0.5mMBt2-cGMP duringthesubjective nightatCT18-19
phase-advanced theelectrical activityrhythmby4.71±0.41
hr(n=4),whereasapplication duringthesubjective dayat
0-
WI
VU)0~~~~~
6-
04- 0
0
2-
o0%*s:0
-2 -I mi1i11a .1
04812162024
Circadian time(hr)
FIG.2.Phase-response curvefor1-hrtreatments with0.5mM
Br-cGMP. Changes inthephaseoftheelectrical activityrhythminducedbyBr-cGMP treatments invitrovs.unperturbed controls are"
plottedaccording tothecircadian timeoftreatment. Eachdot
indicates theresultofasingleexperiment. Thelargestphasead-
vancesoccurred aftertreatments duringmid-subjective night,whereas treatments duringsubjective dayhadlittleeffect.INeurobiology: Prosser etal.
8T
 - -
-1. .
f
ifI
iA i
6814Neurobiology: Prosseretal.
5
6
4
*~2
81624816248
Circadian time(hr)
FIG.3.Br-cGMP inducesstablephaseshiftsinvitro.Sliceswere
treatedatCT18-19onday1invitro.Peakactivityondays2and3
isatCT0.5and1.0,respectively. Thus,thephaseadvances are
complete within6hrandrepresent stableshiftsoftheunderlyingpacemaker. SeeFig.1fordetails.
CT7hadlittleeffectonthetimeofpeakelectrical activityin
thesubsequent cycle(0.25-hrphasedelay,n=2).
Thedifferential responsiveness oftheSCNclocktoana-
logsofcAMPandcGMPisillustrated inFig.4,wherethe
phase-response curvesfor8-benzylaminoadenosine 3',5'-
cyclicmonophosphate (BzA-cAMP, resultsreplotted from
ref.5)andBr-cGMP areshowntogether. Thisfiguresum-
marizestheresultsof28experiments withBzA-cAMP treat-
mentat16CTsand18experiments withBr-cGMP treatment
at13CTs.Itcanbeseenthatthesensitivities oftheSCN
clocktostimulation ofcAMP-andcGMP-dependent path-waysare12hrout-of-phase andvirtuallynonoverlapping:sensitivity tothecAMPanalogappearsinthesubjective daybetweenCT3and12,whereassensitivity tothecGMPanalog
occursinthesubjective nightbetween CT14and22.
DISCUSSION
Theseresultsdemonstrate thatthephaseoftheSCNpace-
makercanberesetinvitrobytreatments thatselectivelystimulate cGMP-dependent pathways. Further,theyindicate
thattheSCNclockissensitive tocGMPanalogsonlyduringthesubjective nightofthecircadian cycle,atimewhenlightstimuliinvivoadvancebehavioral rhythms. Thesensitivity of
theSCNtocGMPanalogsoccursinantiphase tothetimeof
sensitivity tocAMPanalogs.Thus,theseresultssuggestthat
thechanging sensitivity oftheorganism toresetting stimuli
mayhaveitsorigin,atleastinpart,inthedifferential
8
7
6
,~5i5tFXA/ \
4--I
)2
0-
04812162024
Circadian time(hr)
FIG.4.Combined phase-response curvesfor1-hrtreatments of
0.5mMBzA-cAMP (dashedline)andBr-cGMP (solidline).Changes
inthephaseoftheSCNelectrical activityrhythminducedbythese
treatments areplottedaccording totheCToftreatment. The
phase-response curveforBzA-cAMP isbasedupon28experiments
over16CTs(replotted fromref.5).ThedataforBr-cGMP, replotted
fromFig.2,isbasedupon18experiments at13CTs.Proc.Natl.Acad.Sci.USA86(1989)
sensitivity oftheSCNtostimulation ofcGMP-orcAMP-
dependent pathways.
Thephaseadvances inducedbythese1-hrtreatments with
cGMPanalogsarerobustandappeartobecomplete within
6hroftreatment. Intheseaspectsthephaseshiftsinducedby
Br-cGMP andBt2-cGMP aresimilartothoseinduced bya
seriesofthree10-minpulsesofhigh(50mM)K+invitro,
whichalsophase-advances therhythm6-7hrwhenapplied
between CT17and19(24).TheabilityofcGMPanalogs to
phase-shift onlyatnightisalsosimilartotheeffectsofseveral
invivotreatments, including lightpulses(9)andelectrical
stimulation (25).Although themechanisms through which
thesetreatments shifttheSCNpacemaker haveyettobe
determined, ourresultssuggestthatatleastonestepin
nighttime phaseshiftingmayinvolveelevating endogenous
cGMPwithinsomeSCNneurons.
Onehypothesis thatisconsistent withthesedataisthatin
intactanimalslightpulsesduringmid-subjective nightexcite
opticnerveafferents toreleasetransmitter thatstimulates
guanylate cyclase.Theincreased levelofcGMPcouldinturn
stimulate phosphorylation ofoneormoreproteins present
onlyduringthecGMP-sensitive periodandtherebyaltertheir
activity.Theconsequence couldbeacellularchangeinstate
thatadvances thepacemaker toanewphase,fromwhich
time-keeping proceeds normally. Tobegintestingthishy-
pothesis onecouldinvestigate whether lightoropticnerve
stimulation caninduceincreases incGMPlevelsintheSCN.
Photicstimulation hasbeenshowntoincrease cGMPlevels
inseveralothersystems, including theocularcircadian
pacemaker ofmollusks (26).
ThephaseoftheSCNclock'ssensitivity toBr-cGMP
differsbynearly12hrfromitssensitivity tocAMPanalogs,
including 8-bromoadenosine 3',5'-cyclic monophosphate,
andtreatments thatincrease endogenous cAMPlevels(4,5).
Theseresultsareimportant forseveralreasons. First,they
supportthehypothesis thatBr-cGMP phase-shifts theclock
through stimulation ofcGMP-dependent pathways, rather
thanthroughnonspecific effects.Sincethemolecular struc-
turesofthebromoanalogsofcGMPandcAMPdifferonly
slightly(22),theyshouldhavesimilarnonspecific effects.
However, theyactontheSCNclockduringalmostnon-
overlapping times,andthuseachanalogappearstoaffectthe
SCNthroughitsseparate specificactions.Thisconclusion is
furthersupported bythedatashowing thatasecondcGMP
analog,Bt2-cGMP, alsophase-advances theSCNwhenap-
pliedduringthesubjective nightbutnotduringthesubjective
day.
Second,theseresultsindicatethattheisolatedSCNclock
retainsthecharacteristic ofdifferential day-night sensitivity
tophase-shifting agentsseeninvivo.Inthisregard,cGMP
canbegroupedwithinvivotreatments, including lightpulses
(9),carbachol (refs.16and17;however, seealsoref.15),and
electrical stimulation (25),thatphase-shift rodentcircadian
rhythms whenappliedduringsubjective night.Conversely,
cAMPappearstoactlikeaseparate groupofinvivotreat-
mentsthatphase-advance onlywhenappliedduringsubjec-
tiveday,including darkpulses(10,11),neuropeptide Y(12),
andglutamate (14).Theretention bytheisolatedSCNof
differential day-night sensitivity toresetting stimulisupports
theideathattheseseparate entrainment pathways actona
clockthatitselfchanges withtheprocession oftime.Itafso
reinforces theevidence thattheSCNcontainanautonomous
circadian clockthatcontinues tofunction normally when
isolatedinabrain-slice preparation.
Third,theseresultsstrongly support theconclusion that
cAMPandcGMPaffecttheSCNcircadian pacemakerthroughseparatebiochemical pathways. Theirsiteofaction
couldbewithinpathways afferenttothepacemaker orwithin
thetime-keeping mechanism itself.Ineithercase,theindi-
cationthatthesetwocyclicnucleotides accessdifferent,
Proc.Natl.Acad.Sci.USA86(1989) 6815
temporally limitedcomponents mayprovideadditional clues
astobiochemical substrates withintheSCN.Forexample,
cAMPmayaffectthepacemaker throughphosphorylating
proteins available onlyduringtheday;conversely, cGMP
mayactthroughphosphorylating proteinsthatareavailable
onlyduringthenight.Eachphosphorylated substrate would
havetheabilitytomaximally advance thepacemaker by
nearlyaquarterofitscycle.Preliminary evidence suggests
thatindeedthereareday-night differences inproteinand
phosphoprotein profilesintheSCNinvivo(27,28).Thus,
proteinchanges mayunderlie thedifferential sensitivity of
theSCNclocktoresetting bycAMPandcGMP.
Theresultsofprevious experiments providefurthersup-
portforthehypothesis thatcAMPandcGMPmayplay
differential roleswithinthehypothalamus, and,morespe-
cifically, withintheSCN.ThelevelsofcAMPandcGMP
havebeenshowntooscillate 1800out-of-phase witheach
otherinfreshlydissected hypothalami ofrat,withcAMP
levelshighintheearlydayandcGMPlevelshighintheearly
night(29).Also,cGMPandcAMPanalogshavebeenshown
toincreaseanddecrease thefiringratesofsomeSCNcellsin
vitro,respectively (30).However, interpretation ofthese
resultswithrespecttotheabilityofcAMPandcGMPanalogs
toresettheSCNpacemaker isdifficult, sinceitisnotknown
atwhatCTthesetreatments wereperformed.
Thedifferential sensitivity oftheSCNclocktocAMPand
cGMPanalogsisinsomewayssimilartothatseeninthe
circadian pacemaker locatedintheAplysia eye.Inthe
isolatedeyepreparation ofthismollusk, 6-hrtreatments with
Br-cGMP inducephaseadvances whenappliedduringsub-
jectivenightandphasedelaysduringsubjective day;con-
versely,6-hrtreatments withBzA-cAMP inducephasead-
vanceswhenappliedduringthesubjective dayandphase
delaysduringsubjective night(26,31).Severaldifferences
between thesetwosystemsshouldbenoted,however. (i)
Br-cGMP andBzA-cAMP appeartoinduceonlyphase
advances intheSCNpacemaker, whereastheyinduceboth
advances anddelaysinAplysia. (ii)WhileBzA-cAMP and
Br-cGMP appeartophase-shift theSCNduringnonoverlap-
ping12-hrperiods, theseanalogsaffecttheAplysia eye
pacemaker duringoverlapping phases,although theypro-
duceopposite changes. (iii)ThephaseshiftsseenintheSCN
clockafter1-hrtreatments ofBzA-cAMP andBr-cGMP are
muchlargerthanthoseseeninAplysiaafter6-hrtreatments
withtheseanalogs. Thus,although bothpacemakers appear
tobedifferentially sensitive toBzA-cAMP andBr-cGMP,
theirresponses totheseanalogsdifferbothqualitatively and
quantitatively.
Inconclusion, theSCNpacemaker isresetinvitroby
nighttime butnotdaytime treatments thatstimulate cGMP-
dependent pathways, suggesting thatcGMPmayunderlie
someaspectsoflight-induced phaseshiftsinvivo.The
actionsofcGMPmustresideeitherwithintheSCNpace-
makerorwithinapathway accessing it.Nocturnal sensitivity
tocGMPisdistinctfromtheSCN'ssensitivity tocAMP,
whichisrestricted tothesubjective daytime. Thisdifferentialsensitivity tocAMPandcGMPparallels thedifferential
day-night sensitivity oftheSCNtoavarietyofinvivo
treatments andsuggests thatthesecyclicnucleotides nor-
mallymayactontheSCNcircadian clockthrough the
stimulation ofseparate biochemical pathways.
WethankDr.RhanorGilletteforcriticalreadingofthemanu-
script.Thisworkwassupported byGrantNS22155fromthe
National InstituteofNeurological andCommunicative Disorders and
Stroke.
1.Rusak,B.&Zucker,I.(1979)Physiol. Rev.59,449-526.
2.Moore,R.Y.(1979)inEndocrine Rhythms, ed.Krieger, D.T.
(Raven,NewYork),pp.63-87.
3.Turek,F.W.(1985)Annu.Rev.Physiol. 47,49-64.
4.Gillette, M.U.&Prosser, R.A.(1988)BrainRes.474,348-
352.
5.Prosser, R.A.&Gillette, M.U.(1989)J.Neurosci. 9,1073-
1081.
6.Gillette, M.U.(1986)BrainRes.379,176-181.
7.Inouye,S.-I.T.&Kawamura, H.(1979)Proc.Natl.Acad.Sci.
USA76,5962-5966.
8.Daan,S.&Pittendrigh, C.S.(1976)J.Comp.Physiol. 106,
253-266.
9.DeCoursey, P.J.(1964)J.Comp.Cell.Physiol.63,189-1%.10.Boulos,Z.&Rusak,B.(1982)J.Comp.Physiol.146,411-417.
11.Ellis,G.B.,McKlveen, E.&Turek,F.W.(1982)Am.J.
Physiol. 242,R44-R50.
12.Albers,H.E.&Ferris,C.F.(1984)Neurosci. Lett.50,163-
168.
13.Earnest, D.J.&Turek,F.W.(1985)Proc.Nati.Acad.Sci.
USA82,4277-4281.
14.Meijer,J.H.,vanderZee,E.A.&Dietz,M.(1988)Neurosci.
Lett.86,177-183.
15.Meijer,J.H.,vanderZee,E.&Dietz,M.(1988)J.Biol.
Rhythms 3,333-348.
16.Zatz,M.&Brownstein, M.J.(1979)Science203,358-361.
17.Zatz,M.&Herkenham, M.A.(1981)BrainRes.212,234-238.
18.Waldman, S.A.&Murad,F.(1987)Pharmacol. Rev.39,
163-195.
19.Dudai,Y.(1987)CRCCrit.Rev.Biochem. 22,221-281.
20.Goldberg, N.D.,Haddox, M.K.,Nicol,S.E.,Glass,D.B.,
Sanford, C.H.,Kuehl,F.A.&Estensen, R.(1975)Adv.Cyclic
Nucleotide Res.5,307-330.
21.Hatton,G.I.,Doran,A.D.,Salm,A.K.&Tweedle, C.D.
(1980)BrainRes.Bull.5,405-414.
22.Meyer,R.B.&Miller,J.P.(1974)LifeSci.14,1019-1040.
23.Simon,L.N.,Shuman, D.A.&Robins, R.K.(1973)Adv.
CyclicNucleotide Res.3,225-353.
24.Gillette, M.U.(1987)Soc.Neurosci. Abstr.13,51.
25.Rusak,B.&Groos,G.(1982)Science215,1407-1409.
26.Eskin,A.,Takahashi, J.S.,Zatz,M.&Block,G.D.(1984)J.
Neurosci. 4,2466-2471.
27.Gillette, M.,Reiman, A.M.&Lipeski, L.E.(1986)Soc.
Neurosci. Abstr.12,845.
28.Roberts, M.H.&Moore,R.Y.(1986)Soc.Neurosci. Abstr.
12,211.
29.Valases,C.,Wright,S.J.,Jr.,&Catravas, G.N.(1980)Exp.
BrainRes.40,261-264.
30.Liou,S.Y.,Shibata, S.,Shiratsuchi, A.&Ueki,S.(1986)
Neurosci. Lett.67,339-343.
31.Eskin,A.,Corrent, G.,Lin,C.-Y.&McAdoo, D.J.(1982)Proc.Natl.Acad.Sci.USA79,660-664.Neurobiology: Prosser etal.
